Curetis Partners with Acumen Research Laboratories

Curetis AG of German obtained a world-wide, non-exclusive license to AcuSept, a proprietary biomarker panel, from Acumen Research Laboratories of Singapore. Separately, Acumen signed exclusive, multi-year distribution agreement with Curetis for Unyvero production line, a diagnostics system for severe infectious diseases, in Association of Southeast Asian Nations (ASEAN).The two companies will jointly develop a sepsis host response test based on the AcuSept panel and the Unyvero platform. More details.... Share this with colleagues: // //